The Triological Society – American The Laryngological, Rhinological and Otological Society

Submission of Triological Society Abstract

After you submit your form, you will be provided with an online receipt with a copy of your full submission for your records.

- Step 1 of 5

FOR ADMIN ONLY: Review Group (This field will be updated when the abstract is processed.)

Abstract Submission Form

Policy Agreement *

All Authors Agree to Comply with the Policy Stated on the Previous Page

General Questions

The answers to the questions below will not influence the evaluation of your submission. These are for information gathering purposes only.

1. If selected, will this be your first presentation at a national meeting? *

2. If you selected no, what was the first national meeting you attended?

3. Is this your first time going to a national meeting? *

4. Have you been the recipient of a TRIO Travel Award in the past? *

5. Please list your personal social media handles if any.

6. Please list your institution's social media handles if any.

Select Meeting

Abstracts may only be submitted for one meeting. If you have already submitted an abstract, please do not resubmit it.

Combined Sections Meeting *

Triological Society 2027 Combined Sections Meeting, January 21-23, 2027, at Hyatt Regency in Huntington Beach, California

Annual Meeting *

Triological Society 129th Annual Meeting, April 7-11, 2027, at Sheraton Grand in Seattle, Washington

Use the list below to determine which section to select:

Eastern Section
Connecticut
Massachusetts
Maine
New Brunswick
New Hampshire
New Jersey
New York
Newfoundland
Nova Scotia
Ontario
Pennsylvania
Quebec
Rhode Island
Vermont

Middle Section
Iowa
Illinois
Indiana
Kansas
Manitoba
Michigan
Minnesota
Missouri
Nebraska
North Dakota
Ohio
Oklahoma
South Dakota
Wisconsin

Southern Section
Alabama
Arkansas
Delaware
Washington DC
Florida
Georgia
Kentucky
Louisiana
Maryland
Mississippi
North Carolina
Puerto Rico
South Carolina
Tennessee
Texas
Virginia
West Virginia

Western Section
Alaska
Alberta
Arizona
British Columbia
California
Colorado
Hawaii
Idaho
Montana
Nevada
New Mexico
Oregon
Saskatchewan
Washington
Wyoming
Utah

Choose Your Section *

Eastern Section
Middle Section
Southern Section
Western Section

General Abstract Information

Subject *

Allergy/Rhinology
Facial Plastic and Reconstructive
General
General - Education
General - Sleep
Head and Neck
Laryngology/Bronchoesophagology
Otology/Neurotology
Pediatrics

Consider as *

Poster
Oral Presentation
Either

Abstract Submitter Category -- This information is required for the travel award application process.

Submitter Categories *

Otolaryngology Resident Submission: The resident is the first author and presenter OR presenter only
Otolaryngology Fellow Submission: The fellow is the first author and presenter OR presenter only.
Medical Student Submission: The student is the first author and presenter OR presenter only
Submitter is none of the above.

Name of Residency Training Program/Institution *

Name of Department Chairman *

Department Chairman Email *

Expected Date of Completion of Primary Resident Training *

Name of Fellowship Training Program/Institution *

Name of Department Chairman *

Department Chairman Email *

Expected Date of Completion of Fellowship Training *

Name of Otolaryngology Program/Institution *

Name of Otolaryngology Department Chairman *

Department Chairman Email *

First Author Information

First Author's Full Name *

First

Middle

Last

Degree (abbreviation no punctuation) *

Institution

Institution Name *

Institution Address Line 1 *

Address Line 2

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Zip / Postal Code *

First Author Cell Phone *

First Author Email *

Confirm Email

Presenter Information

Is the Presenter someone other than the First Author? *

Presenter's Full Name *

First

Middle

Last

Degree (abbreviation no punctuation) *

Institution

Institution Name *

Institution Address Line 1 *

Address Line 2

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Zip / Postal Code *

Presenter's Cell Phone *

Presenter Email *

Confirm Email

Co-Authors

LIST CO-AUTHORS IN THE ORDER IN WHICH THEY SHOULD APPEAR IN PRINT.

IF A CO-AUTHOR IS THE PRESENTER DO NOT LIST THEM BELOW.

Co-Author Reminder *

I understand that the first author and presenter should not be listed again as a co-author

How Many Co-Authors?

Co-authors: 0

Drag to adjust the slider. You can add up to 5 co-authors.

Co-Author 1

Name of Co-Author 1 *

First

Middle

Last

Degree (abbreviation no punctuation) *

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Email *

Co-Author 2

Name of Co-Author 2 *

First

Middle

Last

Degree (abbreviation no punctuation) *

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Email *

Co-Author 3

Name of Co-Author 3 *

First

Middle

Last

Degree (abbreviation no punctuation) *

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Email *

Co-Author 4

Name of Co-Author 4 *

First

Middle

Last

Degree (abbreviation no punctuation) *

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Email *

Co-Author 5

Name of Co-Author 5 *

First

Middle

Last

Degree (abbreviation no punctuation) *

City *

State or Country *

Please use 2 letter abbreviation for your state if you live in the U.S. and your country if you live elsewhere.

Email *

Confirmations and Acknowledgments

AUTHOR'S ACCEPTANCE OF RESPONSIBILITY: The material in this abstract has not been submitted for publication, published, nor presented previously at another national or international meeting and is not under consideration for presentation at another national or international meeting. I understand that the penalty for duplicate presentation/publication will prohibit me and my co-authors from presenting at a Triological Society meeting or at COSM for three years. I accept sole responsibility for statements in the abstract.

AUTHORIZATION & CONSENT: Authors hereby consent and authorize release and use for teaching and research purposes any and all photographs, films or the recorded media taken of presentation. Authors understand, should the abstract be accepted for publication, The Laryngoscope or Laryngoscope Investigative Otolaryngology has exclusive rights to publication of accompanying paper.

MANUSCRIPT RESPONSIBILITY: Upon acceptance of this submission for oral presentation the author agrees to provide a manuscript to The Laryngoscope or Laryngoscope Investigative Otolaryngology editorial office.

First author agrees to comply with all the above statements as indicated by entering name of submitter and today’s date:

Submitter's Full Name *

Today's Date

Submitter's Email *

Confirm Email

Abstract Content

Keep Abstracts Anonymous *

Do not include references to authors, institutions or geographical locations in the title or main body/text of the abstracts as all abstracts are reviewed anonymously.

Title *

Capitalize the first letter of all words of four letters or more.

Educational Objective *

Abstract (try to keep around 250 words)

Please avoid the use of special symbols. If you must use special symbols, check your submitted abstract to verify that the special symbols have correctly translated; if they have not, it is your responsibility to email beth@triological.org with corrections. In particular avoid the use of "less than" and "greater than" symbols within the same section of the abstract otherwise your text may be mistaken for code and be automatically removed as a security measure.

Objectives *

Study Design *

Methods *

Results *

Conclusions *

Financial Disclosures

ACCME and American College of Surgeons logos

Triological Society 2027 Meetings

In accordance with ACCME regulations (ACCME Standard 3), the American College of Surgeons must ensure that anyone who is able to control the content of the activity has disclosed all financial relationships with any ineligible companies in the 24 months prior to their involvement in the educational activity. There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to this education.

Ineligible Company: Companies that are ineligible to be accredited in the ACCME system (ineligible companies) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Financial Relationships: Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education: 1) a financial relationship, in any amount, exists between the person in control of content and an ineligible company; 2) the financial relationship existed in the last 24 months; 3) the content of the education is related to the products of an ineligible company with whom the person has a financial relationship.

Has the Financial Relationship Ended? If the financial relationship has existed during the last 24 months, but has now ended, please check the box in this column. This will help the education staff determine if any mitigation steps need to be taken.

All CME Planners and Speakers /Moderators/Discussants/Authors/Editors etc. involved in the development and/or presentation of CME content must complete this form. This form must be updated whenever circumstances require. As relevant, all disclosure information for speakers must either be revealed by a slide at the beginning of the presentation or verbal prior to start of presentation.

First Author

FA First Name *

Please do not change this field.

FA Last Name *

First Author is an owner or employee of an ineligible company. First Author is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that First Author meets an ACCME exception. *

For more information: ACCME Standard 3.

First Author is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). First Author is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that First Author meets an ACCME exception. *

For more information: ACCME Standard 3

First Author agrees that First Author will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, First Author will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

First Author does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that First Author has a financial relationship with currently or has had in the last 24 months.
2. Explain what First Author received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify First Author's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of First Author's disclosure of a financial relationship with an ineligible company, a designated official will contact First Author to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to First Author's role(s) in the activity.

Ineligible Company Name 1 *

What Was Received *

Role Held with the Ineligible Company (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Please add any additional financial interests here; include (1) Ineligible Company Name (2) What Was Received (3) Role Held with the Ineligible Company (the nature of the relationship) (4) Has the Relationship Ended? (Yes or No)

Presenter

Presenter First Name *

Please do not change this field.

Presenter Last Name *

Presenter is an owner or employee of an ineligible company. Presenter is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Presenter meets an ACCME exception. *

For more information: ACCME Standard 3

Presenter is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Presenter is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Presenter meets an ACCME exception. *

For more information: ACCME Standard 3

Presenter agrees that Presenter will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Presenter will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Presenter does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Presenter has a financial relationship with currently or has had in the last 24 months.
2. Explain what Presenter received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Presenter's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Presenter's disclosure of a financial relationship with an ineligible company, a designated official will contact Presenter to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Presenter's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Co-Author 1

CO1 First Name *

Please do not change this field.

CO1 Last Name *

Co-Author 1 is an owner or employee of an ineligible company. Co-Author 1 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 1 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 1 is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Co-Author 1 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 1 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 1 agrees that Co-Author 1 will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Co-Author 1 will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Co-Author 1 does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Co-Author 1 has a financial relationship with currently or has had in the last 24 months.
2. Explain what Co-Author 1 received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Co-Author 1's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Co-Author 1's disclosure of a financial relationship with an ineligible company, a designated official will contact Co-Author 1 to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Co-Author 1's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Co-Author 2

CO2 First Name *

Please do not change this field.

CO2 Last Name *

Co-Author 2 is an owner or employee of an ineligible company. Co-Author 2 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 2 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 2 is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Co-Author 2 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 2 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 2 agrees that Co-Author 2 will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Co-Author 2 will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Co-Author 2 does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Co-Author 2 has a financial relationship with currently or has had in the last 24 months.
2. Explain what Co-Author 2 received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Co-Author 2's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Co-Author 2's disclosure of a financial relationship with an ineligible company, a designated official will contact Co-Author 2 to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Co-Author 2's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Co-Author 3

CO3 First Name *

Please do not change this field.

CO3 Last Name *

Co-Author 3 is an owner or employee of an ineligible company. Co-Author 3 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 3 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 3 is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Co-Author 3 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 3 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 3 agrees that Co-Author 3 will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Co-Author 3 will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Co-Author 3 does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Co-Author 3 has a financial relationship with currently or has had in the last 24 months.
2. Explain what Co-Author 3 received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Co-Author 3's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Co-Author 3's disclosure of a financial relationship with an ineligible company, a designated official will contact Co-Author 3 to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Co-Author 3's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Co-Author 4

CO4 First Name *

Please do not change this field.

CO4 Last Name *

Co-Author 4 is an owner or employee of an ineligible company. Co-Author 4 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 4 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 4 is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Co-Author 4 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 4 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 4 agrees that Co-Author 4 will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Co-Author 4 will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Co-Author 4 does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Co-Author 4 has a financial relationship with currently or has had in the last 24 months.
2. Explain what Co-Author 4 received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Co-Author 4's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Co-Author 4's disclosure of a financial relationship with an ineligible company, a designated official will contact Co-Author 4 to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Co-Author 4's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Co-Author 5

CO5 First Name *

Please do not change this field.

CO5 Last Name *

Co-Author 5 is an owner or employee of an ineligible company. Co-Author 5 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 5 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 5 is a stockholder of a privately held ineligible company (not through a mutual fund or pension plan). Co-Author 5 is to be excluded from controlling content or participating as faculty in accredited education unless the planning chair determines that Co-Author 5 meets an ACCME exception. *

For more information: ACCME Standard 3

Co-Author 5 agrees that Co-Author 5 will not accept honoraria, travel expenses, in-kind contributions, or any other support from commercial companies/ineligible companies in connection with this activity. *

I agree

If any of the information reported above changes, Co-Author 5 will notify ACS immediately and update this form accordingly. *

I agree

To report changes contact beth@triological.org.

Co-Author 5 does have / does not have personal financial relationship(s) with any ineligible companies as defined above. *

Does Have
Does Not Have

If the answer above is "does have" you are REQUIRED to:
1. List the names of companies that Co-Author 5 has a financial relationship with currently or has had in the last 24 months.
2. Explain what Co-Author 5 received (i.e. salary, honorarium, stock options, travel expenses, etc.).
3. Specify Co-Author 5's role (i.e., planner, faculty, author, content creator, content reviewer, moderator, and/or other roles in control of educational content) in the activity.
4. Indicate Yes or No if the financial relationship has ended.
5. As a result of Co-Author 5's disclosure of a financial relationship with an ineligible company, a designated official will contact Co-Author 5 to discuss the possible conflict of interest and determine the strategy to mitigate all relevant financial relationships appropriate to Co-Author 5's role(s) in the activity.

Ineligible Company Name 1 *

What I Received *

For What Role (the nature of the relationship) *

Has the Relationship Ended? (Yes or No) *

Ineligible Company Name 2

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Ineligible Company Name 3

What I Received

For What Role (the nature of the relationship)

Has the Relationship Ended? (Yes or No)

Confirmations and Acknowledgments

By typing my name below, I certify that I have identified and disclosed all financial relationships with any ineligible companies (in the last 24 months) and that all information provided herein is true and correct. Entering your name next to the date indicates compliance. This is required.

Today's Date *

Name *

If you are certain that all forms are complete and accurate, please click Submit. After you click Submit, a confirmation page will appear indicating that your abstract has been successfully received. No separate confirmation email will be sent.

Name